Pimobendan (Vetmedin) is the first-line medication for treating mitral valve disease (MVD) in dogs. Here’s a summary of how it works, when to administer it, potential side effects, and key care tips every pet owner should know.


| Item | Stage B1 | Stage B2 | Stage C (CHF) |
|---|---|---|---|
| Heart size | Within normal range | Enlarged | Markedly enlarged with symptoms present |
| Symptoms | None | None (asymptomatic) | Cough, dyspnea, syncope |
| Pimobendan administration | False | True | True |
| Expected effect | Not applicable | Delays onset of heart failure | Prolongs survival time |
Early administration starting from Stage B2 is the standard treatment proven in the EPIC study
What to Check Before Using Pimobendan
Pimobendan is a medication that should only be prescribed after confirming Stage B2 via an echocardiogram. It is not a drug to be used simply because a heart murmur is detected. In fact, it can be harmful in cases of hypertrophic cardiomyopathy (HCM) or certain outflow obstruction diseases. The decision to administer this medication must be based on the results of an echocardiogram performed by a veterinarian.

Concomitant Medications and Emergency Warning Signs
Pimobendan is typically prescribed alongside diuretics (furosemide), ACE inhibitors (enalapril), and spironolactone. This combination is commonly referred to as "quadruple heart therapy." If your dog’s resting respiratory rate remains above 40 breaths per minute, if their tongue turns blue, or if they suddenly collapse, seek emergency veterinary care immediately, as these may be signs of acute pulmonary edema.

A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.
Share
[1] Häggström J, Boswood A, et al., Effect of Pimobendan on Survival in Dogs with Preclinical MMVD (EPIC Trial), J Vet Intern Med, 2016
[2] Ljungvall I, Häggström J, Myxomatous Valvular Disease, Textbook of Cardiovascular Medicine in Dogs and Cats
[3] Stern JA, Walker AL, Pimobendan, Small Animal Critical Care Medicine, 3rd Ed